Michael Chen to Neuroprotective Agents
This is a "connection" page, showing publications Michael Chen has written about Neuroprotective Agents.
Connection Strength
0.063
-
Aupperle PM, Koumaras B, Chen M, Rabinowicz A, Mirski D. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Curr Med Res Opin. 2004 Oct; 20(10):1605-12.
Score: 0.063